Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety
Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chi...
Gespeichert in:
Veröffentlicht in: | Pharmaceuticals (Basel, Switzerland) Switzerland), 2020-02, Vol.13 (3), p.34, Article 34 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | 34 |
container_title | Pharmaceuticals (Basel, Switzerland) |
container_volume | 13 |
creator | Shoda, Takuji Ohoka, Nobumichi Tsuji, Genichiro Fujisato, Takuma Inoue, Hideshi Demizu, Yosuke Naito, Mikihiko Kurihara, Masaaki |
description | Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chimeric compounds that recruit the aryl hydrocarbon receptor (AhR) E3 ligase complex and induce the AhR-dependent degradation of target proteins. However, these chimeras contain a hydrophobic AhR E3 ligand, and thus, degrade target proteins even in cells that do not express AhR. In this study, we synthesized new compounds in which the AhR ligands were replaced with a hydrophobic adamantane moiety to investigate the mechanisms of AhR-independent degradation. Our results showed that the compounds, 2, 3, and 16 induced significant degradation of some target proteins in cells that do not express AhR, similar to the chimeras containing AhR ligands. However, in cells expressing AhR, 2, 3, and 16 did not induce the degradation of other target proteins, in contrast with their response to chimeras containing AhR ligands. Overall, it was suggested that target proteins susceptible to the hydrophobic tagging system are degraded by chimeras containing hydrophobic AhR ligands even without AhR. |
doi_str_mv | 10.3390/ph13030034 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3390_ph13030034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_eea8d0eaf35a447d86d0789256ee0c02</doaj_id><sourcerecordid>2369422466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-99db8779e8f0a5ba776201c9db8e516e7d351b4be988c4c0cd580807b6e6a0c63</originalsourceid><addsrcrecordid>eNqNUsFu1DAQjRCIlsKFD0A-ItDCOHZi54JUhUIrLYJDOVuOPcm6SuLFdor27_F2y9LeuNijeW_ePPm5KF5T-MBYAx-3G8qAATD-pDilvOQrWXLx9EF9UryI8QagEpTT58UJKynUFYjTAq91GDChJT-CT-hm8hmHoK1Ozs-k25F24yYMzpDWT1u_zDaSJbp5IJc7G_x247uMXTCydoPeg_kg51ZPek56RvLNO0y7l8WzXo8RX93fZ8XPLxfX7eVq_f3rVXu-XpmKQlo1je2kEA3KHnTVaSHqEqjZd7GiNQrLKtrxDhspDTdgbCVBguhqrDWYmp0VVwdd6_WN2gY36bBTXjt11_BhUDokZ0ZUiFpaQN2zSnMurKwtCNmUVY0IBsqs9emgtV26Ca3BOQU9PhJ9jMxuowZ_qwTNXiVkgbf3AsH_WjAmNblocBzzu_glqpLVDS9LXu99vztQTfAxBuyPayiofcbqX8aZ_OahsSP1b6iZIA-E39j5PhqHs8EjDfI3KJkAwXNFRevSXdZtzjbl0ff_P8r-AOQqw0c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2369422466</pqid></control><display><type>article</type><title>Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Shoda, Takuji ; Ohoka, Nobumichi ; Tsuji, Genichiro ; Fujisato, Takuma ; Inoue, Hideshi ; Demizu, Yosuke ; Naito, Mikihiko ; Kurihara, Masaaki</creator><creatorcontrib>Shoda, Takuji ; Ohoka, Nobumichi ; Tsuji, Genichiro ; Fujisato, Takuma ; Inoue, Hideshi ; Demizu, Yosuke ; Naito, Mikihiko ; Kurihara, Masaaki</creatorcontrib><description>Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chimeric compounds that recruit the aryl hydrocarbon receptor (AhR) E3 ligase complex and induce the AhR-dependent degradation of target proteins. However, these chimeras contain a hydrophobic AhR E3 ligand, and thus, degrade target proteins even in cells that do not express AhR. In this study, we synthesized new compounds in which the AhR ligands were replaced with a hydrophobic adamantane moiety to investigate the mechanisms of AhR-independent degradation. Our results showed that the compounds, 2, 3, and 16 induced significant degradation of some target proteins in cells that do not express AhR, similar to the chimeras containing AhR ligands. However, in cells expressing AhR, 2, 3, and 16 did not induce the degradation of other target proteins, in contrast with their response to chimeras containing AhR ligands. Overall, it was suggested that target proteins susceptible to the hydrophobic tagging system are degraded by chimeras containing hydrophobic AhR ligands even without AhR.</description><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph13030034</identifier><identifier>PMID: 32106507</identifier><language>eng</language><publisher>BASEL: Mdpi</publisher><subject>adamantane ; Chemistry, Medicinal ; chimeric compound ; hydrophobic tagging ; Life Sciences & Biomedicine ; Pharmacology & Pharmacy ; protein degradation ; Science & Technology</subject><ispartof>Pharmaceuticals (Basel, Switzerland), 2020-02, Vol.13 (3), p.34, Article 34</ispartof><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>7</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000523707400017</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c510t-99db8779e8f0a5ba776201c9db8e516e7d351b4be988c4c0cd580807b6e6a0c63</citedby><cites>FETCH-LOGICAL-c510t-99db8779e8f0a5ba776201c9db8e516e7d351b4be988c4c0cd580807b6e6a0c63</cites><orcidid>0000-0003-0451-1337</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151680/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151680/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,28253,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32106507$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shoda, Takuji</creatorcontrib><creatorcontrib>Ohoka, Nobumichi</creatorcontrib><creatorcontrib>Tsuji, Genichiro</creatorcontrib><creatorcontrib>Fujisato, Takuma</creatorcontrib><creatorcontrib>Inoue, Hideshi</creatorcontrib><creatorcontrib>Demizu, Yosuke</creatorcontrib><creatorcontrib>Naito, Mikihiko</creatorcontrib><creatorcontrib>Kurihara, Masaaki</creatorcontrib><title>Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety</title><title>Pharmaceuticals (Basel, Switzerland)</title><addtitle>PHARMACEUTICALS-BASE</addtitle><addtitle>Pharmaceuticals (Basel)</addtitle><description>Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chimeric compounds that recruit the aryl hydrocarbon receptor (AhR) E3 ligase complex and induce the AhR-dependent degradation of target proteins. However, these chimeras contain a hydrophobic AhR E3 ligand, and thus, degrade target proteins even in cells that do not express AhR. In this study, we synthesized new compounds in which the AhR ligands were replaced with a hydrophobic adamantane moiety to investigate the mechanisms of AhR-independent degradation. Our results showed that the compounds, 2, 3, and 16 induced significant degradation of some target proteins in cells that do not express AhR, similar to the chimeras containing AhR ligands. However, in cells expressing AhR, 2, 3, and 16 did not induce the degradation of other target proteins, in contrast with their response to chimeras containing AhR ligands. Overall, it was suggested that target proteins susceptible to the hydrophobic tagging system are degraded by chimeras containing hydrophobic AhR ligands even without AhR.</description><subject>adamantane</subject><subject>Chemistry, Medicinal</subject><subject>chimeric compound</subject><subject>hydrophobic tagging</subject><subject>Life Sciences & Biomedicine</subject><subject>Pharmacology & Pharmacy</subject><subject>protein degradation</subject><subject>Science & Technology</subject><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>DOA</sourceid><recordid>eNqNUsFu1DAQjRCIlsKFD0A-ItDCOHZi54JUhUIrLYJDOVuOPcm6SuLFdor27_F2y9LeuNijeW_ePPm5KF5T-MBYAx-3G8qAATD-pDilvOQrWXLx9EF9UryI8QagEpTT58UJKynUFYjTAq91GDChJT-CT-hm8hmHoK1Ozs-k25F24yYMzpDWT1u_zDaSJbp5IJc7G_x247uMXTCydoPeg_kg51ZPek56RvLNO0y7l8WzXo8RX93fZ8XPLxfX7eVq_f3rVXu-XpmKQlo1je2kEA3KHnTVaSHqEqjZd7GiNQrLKtrxDhspDTdgbCVBguhqrDWYmp0VVwdd6_WN2gY36bBTXjt11_BhUDokZ0ZUiFpaQN2zSnMurKwtCNmUVY0IBsqs9emgtV26Ca3BOQU9PhJ9jMxuowZ_qwTNXiVkgbf3AsH_WjAmNblocBzzu_glqpLVDS9LXu99vztQTfAxBuyPayiofcbqX8aZ_OahsSP1b6iZIA-E39j5PhqHs8EjDfI3KJkAwXNFRevSXdZtzjbl0ff_P8r-AOQqw0c</recordid><startdate>20200225</startdate><enddate>20200225</enddate><creator>Shoda, Takuji</creator><creator>Ohoka, Nobumichi</creator><creator>Tsuji, Genichiro</creator><creator>Fujisato, Takuma</creator><creator>Inoue, Hideshi</creator><creator>Demizu, Yosuke</creator><creator>Naito, Mikihiko</creator><creator>Kurihara, Masaaki</creator><general>Mdpi</general><general>MDPI</general><general>MDPI AG</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0451-1337</orcidid></search><sort><creationdate>20200225</creationdate><title>Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety</title><author>Shoda, Takuji ; Ohoka, Nobumichi ; Tsuji, Genichiro ; Fujisato, Takuma ; Inoue, Hideshi ; Demizu, Yosuke ; Naito, Mikihiko ; Kurihara, Masaaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-99db8779e8f0a5ba776201c9db8e516e7d351b4be988c4c0cd580807b6e6a0c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>adamantane</topic><topic>Chemistry, Medicinal</topic><topic>chimeric compound</topic><topic>hydrophobic tagging</topic><topic>Life Sciences & Biomedicine</topic><topic>Pharmacology & Pharmacy</topic><topic>protein degradation</topic><topic>Science & Technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shoda, Takuji</creatorcontrib><creatorcontrib>Ohoka, Nobumichi</creatorcontrib><creatorcontrib>Tsuji, Genichiro</creatorcontrib><creatorcontrib>Fujisato, Takuma</creatorcontrib><creatorcontrib>Inoue, Hideshi</creatorcontrib><creatorcontrib>Demizu, Yosuke</creatorcontrib><creatorcontrib>Naito, Mikihiko</creatorcontrib><creatorcontrib>Kurihara, Masaaki</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shoda, Takuji</au><au>Ohoka, Nobumichi</au><au>Tsuji, Genichiro</au><au>Fujisato, Takuma</au><au>Inoue, Hideshi</au><au>Demizu, Yosuke</au><au>Naito, Mikihiko</au><au>Kurihara, Masaaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><stitle>PHARMACEUTICALS-BASE</stitle><addtitle>Pharmaceuticals (Basel)</addtitle><date>2020-02-25</date><risdate>2020</risdate><volume>13</volume><issue>3</issue><spage>34</spage><pages>34-</pages><artnum>34</artnum><issn>1424-8247</issn><eissn>1424-8247</eissn><abstract>Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chimeric compounds that recruit the aryl hydrocarbon receptor (AhR) E3 ligase complex and induce the AhR-dependent degradation of target proteins. However, these chimeras contain a hydrophobic AhR E3 ligand, and thus, degrade target proteins even in cells that do not express AhR. In this study, we synthesized new compounds in which the AhR ligands were replaced with a hydrophobic adamantane moiety to investigate the mechanisms of AhR-independent degradation. Our results showed that the compounds, 2, 3, and 16 induced significant degradation of some target proteins in cells that do not express AhR, similar to the chimeras containing AhR ligands. However, in cells expressing AhR, 2, 3, and 16 did not induce the degradation of other target proteins, in contrast with their response to chimeras containing AhR ligands. Overall, it was suggested that target proteins susceptible to the hydrophobic tagging system are degraded by chimeras containing hydrophobic AhR ligands even without AhR.</abstract><cop>BASEL</cop><pub>Mdpi</pub><pmid>32106507</pmid><doi>10.3390/ph13030034</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-0451-1337</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1424-8247 |
ispartof | Pharmaceuticals (Basel, Switzerland), 2020-02, Vol.13 (3), p.34, Article 34 |
issn | 1424-8247 1424-8247 |
language | eng |
recordid | cdi_crossref_primary_10_3390_ph13030034 |
source | DOAJ Directory of Open Access Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | adamantane Chemistry, Medicinal chimeric compound hydrophobic tagging Life Sciences & Biomedicine Pharmacology & Pharmacy protein degradation Science & Technology |
title | Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T14%3A07%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeted%20Protein%20Degradation%20by%20Chimeric%20Compounds%20using%20Hydrophobic%20E3%20Ligands%20and%20Adamantane%20Moiety&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=Shoda,%20Takuji&rft.date=2020-02-25&rft.volume=13&rft.issue=3&rft.spage=34&rft.pages=34-&rft.artnum=34&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph13030034&rft_dat=%3Cproquest_cross%3E2369422466%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2369422466&rft_id=info:pmid/32106507&rft_doaj_id=oai_doaj_org_article_eea8d0eaf35a447d86d0789256ee0c02&rfr_iscdi=true |